BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200414
DTEND;VALUE=DATE:20200418
DTSTAMP:20260515T052528
CREATED:20191105T115338Z
LAST-MODIFIED:20200407T153017Z
UID:23236-1586822400-1587167999@www.pharmajournalist.com
SUMMARY:eyeforpharma Philadelphia Virtual
DESCRIPTION:“As we self-isolate\, we must be careful not to isolate our ideas and thoughts. Ironically\, it has never been more important for our industry to share\, collaborate and inspire. For that reason\, we have not cancelled the eyeforpharma Philadelphia meeting\, but we’re moving it online. It is also now entirely free of charge to attend. I’m humbled that the speakers and supporters that were due to present are moving online with us\, and share with us a desire to ‘do what we can’ to make sure that we carry on communicating. I believe the event will be stronger than ever\, and more influential – at just the right time.” \n \nPaul Simms\, Chairman\, eyeforpharma \nWhy eyeforpharma Philadelphia Virtual is essential viewing: \n\nIt’s free for all to join: In such a difficult time\, we want to unify the industry and we’ve taken the decision to allow anyone to sign up to listen live\, ask questions and participate. If you work for a pharma or biotech\, you’ll also get access to a full meeting service so you can set up bespoke 1-1 meetings with fellow attendees.\n\n\nA speaker faculty even better than before: You’ll learn from 100+ speakers with 60+ free sessions – presentations\, panels\, fireside chats\, interactive workshops and Q&A\, You’ll also see hours of additional live and on-demand content\, including never-before-seen interviews with Kabir Nath\, President & CEO North America\, Otsuka\, Julie Gerberding\, EVP and Chief Patient Officer\, Communications\, Global Policy and Population Health\, Merck\, James Musick\, VP and Head of Digital Transformation\, Neurology\, UCB\, and many more.\n\n\nConnect with industry leaders around the world: Without the constraints of geography\, we’ll have thousands of industry leaders from across the globe coming together to network and collaborate.\n\n\nComplete virtual meetings platform: Send messages to connect 1-on-1 with your fellow attendees. Schedule meetings and use a virtual private meeting room to chat.\n\n\nFull virtual exhibition: Showcasing over 50+ exhibitors\, search for the latest services and technology solutions from your desk\, watch demo videos and the ability to share your virtual business card.\n\nRegister for FREE here: https://bit.ly/2UPFCVZ Join the conversation and become healthcare’s solution.
URL:https://www.pharmajournalist.com/event/eyeforpharma-philadelphia-virtual/
LOCATION:Online\, PA
ORGANIZER;CN="eyeforpharma":MAILTO:ksharp@eyeforpharma.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200415
DTEND;VALUE=DATE:20200418
DTSTAMP:20260515T052528
CREATED:20191215T132554Z
LAST-MODIFIED:20191215T132652Z
UID:23361-1586908800-1587167999@www.pharmajournalist.com
SUMMARY:Neuroimmunology Drug Development Summit 2020
DESCRIPTION:More and more pharma and biotech companies are investing in research focused on neuroimmunology and neuroinflammation’s relation to neurodegenerative diseases in the challenge to develop clinically effective therapeutics. \n \nThe 2nd Neuroimmunology Drug Development Summit’s agenda has specifically designed alongside neuroimmunology experts from the likes of Denali\, AbbVie and Biogen to help these drug developers to overcome their translational challenges and successfully translate their drug candidates into the clinic. \nImmerse yourself in the field’s cutting-edge scientific advances and take this unrivaled opportunity to join over 23 expert industry speakers and over 80 drug developers from the neuroimmunological community for over 7 hours of dedicated networking time and 2 deep-dive workshops. \nTo find out more and view the full speaker line-up\, download the full event guide.
URL:https://www.pharmajournalist.com/event/neuroimmunology-drug-development-summit-2020/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200420
DTEND;VALUE=DATE:20200423
DTSTAMP:20260515T052528
CREATED:20200309T093538Z
LAST-MODIFIED:20200309T093538Z
UID:24547-1587340800-1587599999@www.pharmajournalist.com
SUMMARY:2nd Digital Health  for Pharma (DH4P)
DESCRIPTION:Digital Health for Pharma (DH4P) is the leading Digital Health conference specifically developed for pharmaceutical and life science commercial organizations. Co-created by Evolution Road and ExL Events’ Digital Pharma Series teams\, the three-day event serves to educate life science organizations on how best to leverage digital tools to enhance the commercial model of health and pharma; while also educating patients and bridging the gap between knowledge and information\, pre-commercial and commercialization. \n \nFor 2020\, ExL Events and strategic partners at Evolution Road explore five core leverage models of learning: \n\nINVEST\nINCUBATE/ACCELERATE\nCOMMERCIALIZE\nCOLLABORATE\nCO-DEVELOP\n\nLearn more: http://bit.ly/2TJ2cOh
URL:https://www.pharmajournalist.com/event/2nd-digital-health-for-pharma-dh4p/
LOCATION:Philadelphia\, PA\, Philadelphia\, PA\, United States
ORGANIZER;CN="ExL Events%2C a division of Questex%2C LLC":MAILTO:awarren@questex.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200422
DTEND;VALUE=DATE:20200425
DTSTAMP:20260515T052528
CREATED:20200309T092247Z
LAST-MODIFIED:20200309T092247Z
UID:24541-1587513600-1587772799@www.pharmajournalist.com
SUMMARY:9th Digital Marketing for Medical Devices West
DESCRIPTION:Digital Marketing for Medical Devices is the premier event in the west coast for medical device companies to explore best practices and innovations to improve their digital marketing strategy. Med device companies will hear from their peers in the industry as well as marketing agencies who will reveal the most effective methods to market their products in a digital age. \n \nThe event takes place in San Francisco\, one of the largest tech hubs in the world\, as the medical device industry in this region is expanding at a rapid pace. DMMD West provides a platform to assist this rapid expansion. From innovation through research and development\, marketing and data analytics\, communication and branding strategies\, and measuring KPIs and ROIs\, this event serves to assist your organization\, small and large\, along your product life cycle. \nLearn more: http://bit.ly/39xKlke
URL:https://www.pharmajournalist.com/event/9th-digital-marketing-for-medical-devices-west/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
ORGANIZER;CN="ExL Events%2C a division of Questex%2C LLC":MAILTO:awarren@questex.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200428
DTEND;VALUE=DATE:20200501
DTSTAMP:20260515T052528
CREATED:20200218T083428Z
LAST-MODIFIED:20200218T083428Z
UID:24226-1588032000-1588291199@www.pharmajournalist.com
SUMMARY:Manufacturing Assets & Facility Management in Pharma
DESCRIPTION:Pharma\, biotechs and CMOs have witnessed a major transformation with the continued adoption of digital manufacturing and emerging technologies using AI and big data. We have seen pioneers\, including the likes of Sanofi and Merck\, to maximize asset value\, increase plant reliability and ensure production continuity through digitization. \nThe inaugural Manufacturing Assets & Facility Management (MAFM) in Pharma Summit has been specifically designed to help you manage cost pressures and boost productivity through digitization where you will advance various aspects of asset and facility management programs such as clarity of asset inventory\, asset lifecycle\, facility footprint and sustainability. \n \nWhy is this Event for You? Join this cutting-edge discussion to: \n\nGet up to speed with the digital transformation to streamline operations\nFind new approaches to strategic asset management to improve inventory visibility\nUse data to enhance asset utilization and track the full lifecycle of assets\nEmploy energy and sustainability initiatives to reduce utilities spend\nManage MRO processes to improve productivity and reduce costs\n\nImmerse yourself in this industry-led meeting with the likes of Merck\, CSL Behring and Seattle Genetics. This event is dedicated to exploring strategies in the manufacturing environment where you will join 60+ senior experts from functions of Manufacturing Engineering\, Manufacturing Operations\, Facility Management\, Asset Management\, Procurement and Maintenance & Reliability across pharma\, biotech and CMOs. \nRegister with your team today and don’t miss out on this unique meeting to engage with peers and re-define best practice for tomorrow’s operations.
URL:https://www.pharmajournalist.com/event/manufacturing-assets-facility-management-in-pharma/
LOCATION:Wyndham Boston Beacon Hill 5 Blossom Street Boston\, MA\, MA 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200429
DTEND;VALUE=DATE:20200430
DTSTAMP:20260515T052528
CREATED:20200407T145113Z
LAST-MODIFIED:20200407T145318Z
UID:24936-1588118400-1588204799@www.pharmajournalist.com
SUMMARY:Recombinant Chromogenic Assay as Alternate Methods for the Bacterial Endotoxins Test (BET)
DESCRIPTION:Recombinant Chromogenic Assay as Alternate Methods for the Bacterial Endotoxins Test (BET)\nConference: 29 April 2020 – 10am EDT (3pm BST – UK time)\nLocation: WEBINAR\nWebsite: https://www.smi-online.co.uk/pharmaceuticals/webinar/recombinant-chromogenic-assays \nHOSTED BY: Associate of Cape Cod\nLED BY: Veronika Wills\, Manager\, Technical Services\, Associates of Cape Cod \n \nRecently\, there has been a lot of interest associated with the potential use of synthetic (non-animal based) reagents for bacterial endotoxin testing. This webinar will provide an in-depth overview of the global perspective on the use of such reagents\, including their regulatory status. \nThis free to join webinar is sponsored by Associate of Cape Cod\, the one hour webinar will focus on executing a recombinant kinetic chromogenic assay\, testing samples and detailed data interpretation with the primary focus on comparability of the data with conventional amoebocyte lysate- based assays. \nBENEFITS FOR JOINING THE WEBINAR: \nThis interactive webinar will provide the following benefits: \n\nAn overview of global status of recombinant reagents for BET\nA session on kinetic chromogenic testing\nData interpretation\nTroubleshooting kinetic chromogenic assays\nEquivalency of the recombinant reagents to LAL reagents\n\nWHO SHOULD JOIN? \n\nSenior Microbiologists\nLead Scientists\nLaboratory Managers\nQA Specialists\nDrug Substance External Manufacturers\nQC Scientists\nHeads of Quality\nBusiness Development Managers\nPharmaceutical Microbiology Consultants\nHigher Pharmacopoeia Scientists\nAnalytical Standards Specialists\n\nFor full details and to register your free place\, please visit: https://www.smi-online.co.uk/pharmaceuticals/webinar/recombinant-chromogenic-assays
URL:https://www.pharmajournalist.com/event/recombinant-chromogenic-assay-as-alternate-methods-for-the-bacterial-endotoxins-test-bet/
LOCATION:WEBINAR
ORGANIZER;CN="SMi Group":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200504
DTEND;VALUE=DATE:20200508
DTSTAMP:20260515T052528
CREATED:20191215T133346Z
LAST-MODIFIED:20191215T133426Z
UID:23365-1588550400-1588895999@www.pharmajournalist.com
SUMMARY:NASH Summit Boston
DESCRIPTION:The NASH Summit offers a wide range of cutting-edge debates across 4 conference tracks: discovery\, translational\, non-invasive biomarker and clinical drug development\, in addition to a selection of workshops and seminars. This convivial discussion and networking forum has an extensive program set to help you approach your pipeline for the upcoming year. \n \nJoin 80+ speakers\, including our conference Chair Jason Campagna\, Senior Vice President & Global NASH Lead at Intercept\, and 350+ attendees as the community comes together again by addressing their challenges and the consequences of change in the NASH market. \n\nEstablish a plan of action to optimize candidate success by evaluating advances and difficulties and learn from the community’s experience\nTranslate anti-fibrotic efficacy into the clinic by learning about ground-breaking preclinical modalities\nUse the latest practical insights into hepatocyte differentiation to improve your target identification by understanding its impact on immune cells\, ductular reaction and fibrosis\nExamine the payer’s thoughts on the need to biopsy and assess the clinical utility of non-invasive diagnostics in the normal algorithm of care\nConnect NASH reduction in phase 2 and NASH resolution in phase 3 while justifying a systemic approach to address NASH in combination\, as a manifestation of wider metabolic dysfunction\n\nDownload the full event guide or get in touch today for the agenda and speaker line-up!
URL:https://www.pharmajournalist.com/event/nash-summit-boston/
LOCATION:50 Park Plaza at Arlington Street\, Boston\, MA\, 02116-3912\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200511
DTEND;VALUE=DATE:20200513
DTSTAMP:20260515T052528
CREATED:20180202T092329Z
LAST-MODIFIED:20200319T094546Z
UID:9152-1589155200-1589327999@www.pharmajournalist.com
SUMMARY:SMi’s 20th Annual Pain Therapeutics Conference
DESCRIPTION:SMi’s 20th Annual Pain Therapeutics Conference\nDiscover Cutting Edge Research and Novel Therapeutics in the Pipeline \nConference: 11 and 12 May 2020\nLocation: REMOTE ACCESS ONLY\nWebsite: http://www.pain-therapeutics.co.uk/PharmaJournWL \nAnnouncement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only – please register your place at www.pain-therapeutics.co.uk \nThe price to be a part of this conference is £999 (remote access) and registration is available via the conference website at www.pain-therapeutics.co.uk \nThe 20th Annual Conference will overview the current state of pain treatment starting with research essentials including choosing the right preclinical models to overviewing clinical success up to date\, highlighting cutting-edge research and evaluating the potential of drug candidates in the pipelines of leading pharmaceuticals. \n \nThis year we are introducing the Pain Research Essentials theme to closely observe analgesics drug development from a preclinical point of view. Within this theme talks will address the latest biomarker discoveries\, bridging the translational gap\, differences of pain pathology across sexes and consequently\, the need for distinct gender animal models. This will be topped with a panel discussion around novel drug targets in neuropathic pain treatment.  \nPresentations on clinical stage research will highlight current struggles of opioid-based treatments and discuss results of treatments with non-opioid targets; such as the recently researched cannabinoid receptor 2\, nociception/orphanin FQ peptide (NOP) receptor\, ENKephalinase and NGF receptors. Furthermore\, neuro-immune interactions and their role in pain pathology will be discussed as an anticipated approach for providing more effective therapy for chronic pain. Additionally\, the therapeutic efficacy of neurotoxins will be addressed exploring novel botulinum-based constructs.  \nJoin SMi’s leading Pain Therapeutics Conference which will explore the cutting-edge research of novel therapeutics in the pipeline of leading pharmaceutical companies and discuss solutions for the challenges of understanding pain as a heterogenous disease and the diverse treatment approaches it requires. \nEvent Hashtag: #SMiPain \nView the full agenda: http://www.pain-therapeutics.co.uk/PharmaJournWL \nWHO SHOULD ATTEND \nChief Executive Officer\, Chief Scientific Officers\, Chief Medical Officers\, Managing Directors\, CEO\, Head of Department\, Principal Research Scientists\, Clinical lead\, Clinical Operations in the following fields: \n\nPain and Migraine\nInflammation\nChronic Pain\nNeuropathic Pain\nAnalgesic pre-clinical development\nAnaesthesia and Pain Management\nCNS clinical trials\nIon Channel Pharmacology\nPharmacology Intelligence\nTranslational science\nDrug development\nExploratory development\n\nEARLY BIRD-RATES \n\nBOOK BY 28TH FEBRUARY AND SAVE £200\nBOOK BY 31ST MARCH AND SAVE £100
URL:https://www.pharmajournalist.com/event/smi-pain-therapeutics-conference/
LOCATION:REMOTE ACCESS ONLY
ORGANIZER;CN="SMi Group Ltd":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200511
DTEND;VALUE=DATE:20200513
DTSTAMP:20260515T052528
CREATED:20180307T074833Z
LAST-MODIFIED:20200323T125717Z
UID:11545-1589155200-1589327999@www.pharmajournalist.com
SUMMARY:Highly Potent Active Pharmaceutical Ingredients (HPAPI)
DESCRIPTION:SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020. \nAnnouncement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only – please register your place at www.highlypotentapi.com \nThe price to be a part of this conference is £999 (remote access) and registration is available via the conference website www.highlypotentapi.com \n \nHPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology\, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits\, assessing hazards\, implementing risk procures\, translating risk assessment into facility engineering\, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines. \nAttend the conference and join our networking platform for industry professionals to provide you with the expertise to overcome the challenges of the HPAPI industry. \nNetwork and learn from leading professionals such as: \nCHAIR FOR 2020 – Justin Mason-Home\, Director\, HPAPI Project Services Limited \nKEY SPEAKERS INCLUDE: \nPascal Michoux\, Vice President\, Global EHS Teva api & Biologics\, teva API Italy\nWilliam Hawkins\, Manager Occupation Toxicology\, GsK\nBrian Edwards\, Chair\, Pharmaceutical Human Factors Group\, CIeHf\nThomas Adam\, Head of GQA Chemical APIs\, Bayer AG\nIldikó Ziegler\, QA Manager\, Gedeon Richter\nFrancois D’Hooge\, ADC Project Manager\, Gamamabs Pharma\nAndreas Schreiner\, Head of Validation\, Novartis \nFEATURED HIGHLIGHTS: \n\nExplore HPAPI manufacturing with 8 big pharma from both the toxic substance and the employees’ perspective\nGain better understanding of human factors and ergonomics aspects and their role in improving production performance with the Chartered Institute of Ergonomics and Human Factors\nDeep dive into the oncology market and ADC production\, the main driver of the HPAPI industry\nLearn what it takes to create a safety company culture and how to better train your employees on risk perception\n\nView the full agenda: www.highlypotentapi.com \nContact Info: \nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/highly-potent-active-pharmaceutical-ingredients-hpapi/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Ltd.":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200513
DTEND;VALUE=DATE:20200515
DTSTAMP:20260515T052528
CREATED:20190912T073738Z
LAST-MODIFIED:20190912T073738Z
UID:22362-1589328000-1589500799@www.pharmajournalist.com
SUMMARY:4th Annual Global Clinical Trials Connect 2020 - Collaboration\, Innovation and Enhancing Quality in Clinical Trials
DESCRIPTION:The 4th Annual Global Clinical Trials Connect 2020 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research\, clinical trials planning and management. \nKey Highlights \n\nPatient Recruitment and Site selection\nInnovative trial designs\nPartnership & Collaboration – Sponsors\, CROs\, Sites and External Vendors\nPatient centric clinical trials\nNew innovations in Patient Recruitment planning and execution on a clinical trial\nOutsourcing strategies and models\nElectronic Clinical Outcome Assessment and Electronic Patient Reported Outcome\nStreamlined IRT development process\nPharmacovigilance & Clinical Trials\nPost-Clinical Trial closed communities\nHow to future proof your clinical operations\nImplementing Risk Based Monitoring\nStreamlining R&D and lower costs in clinical trials\nAdaptive Trial Model\nClinical Trial Auditing\nReal World Clinical Trial Strategies\nData Quality & Technology\nClinical Data Strategy & Analytics\nClinical Technology and Driving Innovation\nM-Health\, Wearable and Consumer Technology\nBig-Data\, IoT and Artificial Intelligence Technology in Clinical trials\nBlockchain technology for improving clinical research quality
URL:https://www.pharmajournalist.com/event/4th-annual-global-clinical-trials-connect-2020-collaboration-innovation-and-enhancing-quality-in-clinical-trials/
LOCATION:Holiday Inn London – Kensington High St. Wrights Ln\, Kensington\, London W8 5SP\, UK
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200519
DTEND;VALUE=DATE:20200521
DTSTAMP:20260515T052528
CREATED:20200318T114228Z
LAST-MODIFIED:20200318T114228Z
UID:24652-1589846400-1590019199@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials East Coast
DESCRIPTION:Discover effective strategies for outsourcing clinical trial operations to ensure studies run smoothly and within budget \n\nArena International are delighted to announce Outsourcing in Clinical Trials East Coast will be returning to King of Prussia in May for its 11th Annual event!\n\nThe 2020 programme will feature a range of speakers from the likes of GlaxoSmithKline\, Novartis\, Pfizer\, BMS any many more\, who through a variety of interactive session formats will offer insight on promoting successful collaboration between the clinical trials community. Attendees will have the opportunity of taking part in sessions across 3 stages\, each focusing on a different topic area. Whether your role is Clinical Operations\, Technology & Innovation or Clinical Data Management this event can not be missed\n\nWe look forward to seeing you there!
URL:https://www.pharmajournalist.com/event/outsourcing-in-clinical-trials-east-coast/
LOCATION:Valley Forge Casino Resort – 1160 1st Ave\, King of Prussia\, PA 19406\, United States
ORGANIZER;CN="Arena International":MAILTO:kadin.luong@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200525
DTEND;VALUE=DATE:20200531
DTSTAMP:20260515T052528
CREATED:20200511T104035Z
LAST-MODIFIED:20200511T104403Z
UID:25449-1590364800-1590883199@www.pharmajournalist.com
SUMMARY:Digital Health Online Summit
DESCRIPTION:The healthcare industry will never be the same after COVID19. \nHealthcare professionals need to stay aware of the latest digital health activities and keep learning from leading organizations. \n \nDigital Health Online Summit is a 6-day virtual summit\, providing a comprehensive overview of the current digital health activities\, and equipping health professionals with strategies and tactics\, examples and guidelines for a successful healthcare transformation. \nThis online summit will provide you with timely insights into the following areas: \n\nDigital Health – Current Activities in different organizations\nSmart Care\, Patient Centricity and Engagement\nTransformation with VR/AR\, Voice Tech\, IoT\, Wearables\nBig Data\, AI and Machine Learning\nThe digital mindset transformation\nPatient staff engagement and culture change\nNew Horizon\, Innovation and Tomorrow’s Perspectives\n\nWithin each topic\, there will be 5-9 speaking sessions\, using case studies and bringing practical examples. The summit will gather 40 expert speakers from great companies and associations from all around the world\, including Europe\, North America and Australia. \nWhile the standard events require a lot of time\, effort\, logistics\, and significant expenses for travel and accommodation\, Digital Health Online Summit takes advantage of today’s technologies and provides the best content for professionals from all around the world. \nTo mention just some of the speaker’s companies: United Health Group\, HNS\, Dignity Health\, European Health Management Association\, WONCA\, Stanford Virtual Human Interaction Lab\, XpertCare Inc.\, Seton Health Alliance\, Deloitte\, KPMG\, Mednax\, Crossroads Hospice & Palliative Care\, CitiusTech\, Partners HealthCare\, Peninsula Regional Health System\, Philips\, Ramsay Santé and others. \nThis is a great possibility to learn directly from C-Suite executives with unique and timely insights about the digital shift towards better health services. \nHere are just some of the case studies and presentations: \n➤ Visions and Strategies for Virtual care services\n➤ Current Challenges of Digitalization in the Healthcare Industry\n➤ Key components of a successful digital transformation strategy\n➤ How to keep the conversation open with HCPs while they are not available (COVID-19 crisis time)\n➤ Frontline digital healthcare strategy – from business as usual to crisis management\n➤ Digital when possible – physical when needed\n➤ Personalized\, digitally-supported\, out- of-hospital care: A patient case study\n➤Digital Therapeutics: Just Like a pill?\n➤ Innovation in times of a global crisis \nAnd much\, much more. \nFor our members and network\, we have FREE REGISTRATIONS to this great online summit. \nGet your FREE PASS here >> https://www.digitalhealthonlinesummit.com/?utm_source=partner \nHope you can join the event!
URL:https://www.pharmajournalist.com/event/digital-health-online-summit/
LOCATION:Online
ORGANIZER;CN="Digital Health Online Summit":MAILTO:ilya@digitalhealthonlinesummit.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200603
DTEND;VALUE=DATE:20200605
DTSTAMP:20260515T052528
CREATED:20200203T102138Z
LAST-MODIFIED:20200204T132652Z
UID:23987-1591142400-1591315199@www.pharmajournalist.com
SUMMARY:Microbiome Connect: Human
DESCRIPTION:Previously known as North American Microbiome Congress\, Microbiome Connect: Human USA is all about connecting leading academics and biotech companies presenting preclinical and clinical data\, to network\, educate and share knowledge. Join key opinion leaders and 50+ expert speakers across three dedicated tracks of content to examine the latest preclinical and clinical data in extra-intestinal and intestinal indications. \nTo know more about Microbiome Connect: Human please click here.
URL:https://www.pharmajournalist.com/event/microbiome-connect-human/
LOCATION:Boston\, MA\, MA\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200603
DTEND;VALUE=DATE:20200605
DTSTAMP:20260515T052528
CREATED:20200227T151802Z
LAST-MODIFIED:20200227T161250Z
UID:24341-1591142400-1591315199@www.pharmajournalist.com
SUMMARY:Microbiome Connect: Skin
DESCRIPTION:Microbiome Connect: Skin | 3 – 4 June 2020 | Boston\, USA \n \n2019 was a pivotal year for the skin microbiome\, with multinational conglomerates moving into the space\, recognizing the commercial value of skin microbiome-based products as the next step in a consumer’s skincare regime but the innovation doesn’t end there… \nThis year is all about the major advancements of sequencing and analysis in this space\, and how we can use data to inform product development. 2020 is all about the relationship between skin microbiome based-products\, skin conditions\, personalization\, skin-gut supplements\, and anti-aging. \nBuilding on the hugely successful global Skin Microbiome series which brought together over 600 industry leaders from Pharmaceutical\, Beauty and Personal Care\, Independent Skincare Brands\, Bio-techs\, Researchers and Academics\, Kisaco Research presents Microbiome Connect: Skin USA\, an all-encompassing event\, which runs alongside Microbiome Connect: Human USA in Boston\, June 3 – 4. \nTo learn more about this event and to register online\, visit http://bit.ly/3a9rICR
URL:https://www.pharmajournalist.com/event/microbiome-connect-skin/
LOCATION:Boston\, MA\, USA
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200604
DTEND;VALUE=DATE:20200605
DTSTAMP:20260515T052528
CREATED:20200520T101111Z
LAST-MODIFIED:20200520T101548Z
UID:25609-1591228800-1591315199@www.pharmajournalist.com
SUMMARY:HR Life Science Virtual Event
DESCRIPTION:The HR Life Sciences Virtual Event is a WFH friendly forum covering a range of topics affecting HR strategy and talent management\, including telework\, employee communication\, training or re-training – and of course crisis management as we navigate these unchartered waters. We want to provide you with insights and resources from your peers working through unprecedented challenges at their organizations. \nWhether your current work environment is a home office\, kitchen table\, or hiding from the kids in your bathtub\, you can join HR leaders from a diversity of pharma\, biotech and medical device companies  (whether live or at your own pace!) as we chat through front-of-mind topics and solutions.
URL:https://www.pharmajournalist.com/event/hr-life-science-virtual-event/
LOCATION:Online\, Noon EST
ORGANIZER;CN="Worldwide Business Research":MAILTO:hrlifescience@wbresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200617
DTEND;VALUE=DATE:20200619
DTSTAMP:20260515T052528
CREATED:20200123T095148Z
LAST-MODIFIED:20200123T095148Z
UID:23825-1592352000-1592524799@www.pharmajournalist.com
SUMMARY:ACI’s Skin Microbiome Industry Summit
DESCRIPTION:Skin microbiome products have been gaining more momentum in the last few years with more brands starting to develop products\, and personal care giants either starting to develop their own product or investing in start-ups focusing on these. It is a very exciting time for companies looking into this at the moment\, figuring out not only product development & formulation but also marketing strategy to raise more attention to this type of products. Despite huge popularity and early success stories\, there is still a need to learn more on topics such as: defining the skin microbiome\, formulating products\, cosmetics & pharma claims\, regulation for novel products\, latest advances in terms of mapping & profiling technologies\, as well as product testing. \n \n \nACI’s Skin Microbiome Industry Summit\, taking place on the 17th & 18th June 2020 in London\, will bring together the key actors of the industry to help the industry learn from one another\, work together to further grow and create new business opportunities. During the 2 days conference\, the participants will enjoy the various case studies presentations\, panel discussion\, Q&As and networking breaks to get the industry to thrive together. Join us in London for a highly interactive & informative conference\, whilst enjoying the networking opportunities with your peers.
URL:https://www.pharmajournalist.com/event/acis-skin-microbiome-industry-summit/
LOCATION:London\, UK\, United Kingdom
ORGANIZER;CN="ACI":MAILTO:rafael@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200622
DTEND;VALUE=DATE:20200625
DTSTAMP:20260515T052528
CREATED:20191022T082827Z
LAST-MODIFIED:20191022T093157Z
UID:22997-1592784000-1593043199@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China 2020
DESCRIPTION:CPhI & P-MEC China is your gateway to successfully grow your business at the 2nd largest pharma market in the world and your ONE-STOP SHOP pharmaceutical platform connecting the entire pharmaceutical industry chain. On 22-24 June 2020\, CPhI China 2020\, collocated with ICSE China\, NEX China\, and P-MEC China\, will continue its glorious journey and celebrate its 20th anniversary at Shanghai New International Exhibition Centre (SNIEC). The show is to cover an exhibition area of 210\,000 sqm and is expected to draw 3\,400+ exhibitors from over 140 countries and regions and 75\,000+ visits from global industry professionals. \nTo learn more about CPhI & P-MEC China and to register online\, visit www.cphi-china.cn/en
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-2020/
LOCATION:Shanghai New Int’l Expo Centre (SNIEC)\, 2345 Longyang Road\, Shanghai\, China
ORGANIZER;CN="Informa Markets%2C CCCMHPIE%2C Sinoexpo Informa Markets":MAILTO:yingqi.shi@imsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200624
DTEND;VALUE=DATE:20200625
DTSTAMP:20260515T052528
CREATED:20200515T080714Z
LAST-MODIFIED:20200515T080714Z
UID:25507-1592956800-1593043199@www.pharmajournalist.com
SUMMARY:JAK Inhibitors Drug Development Summit – Running Digitally for 2020
DESCRIPTION:Despite the increasingly unpredictable nature of COVID-19\, our commitment to provide educational resources and networking experiences to keep pharmaceutical knowledge thriving and the industry moving forward has not wavered. \n \nTherefore\, we are very excited to announce that the JAK Inhibitors Drug Development Summit has been transformed into an exclusive one-day digital event that will immerse you in discussions on developing the next generation of JAK inhibitors to expand their clinical utility across oncology\, dermatology and autoimmune disease indications. \nThis is your one and only cross-disciplinary JAK inhibitor meeting with all the content and networking opportunities now delivered in a digital format. \nOur community of JAK inhibitor experts are looking forward to connecting with you in the digital world\, including: \n\nLeandro Santos\, Associate Director\, Clinical Sciences Incyte\nMaciej Wieczorek\, Chief Executive Officer\, Celon Pharma\nPiet Wigerinck\, Chief Scientific Officer\, Galapagos\nAnabela Cardoso\, Global Brand Development\, Lead – Immunology\, Eli Lilly\nBrett King\, Associate Professor of Dermatology\, Yale School of Medicine\nMassimo Gadina\, Chief Translational Immunology Section\, National Institute of Arthritis & Musculoskeletal & Skin Diseases\n\nDon’t miss this opportunity to hear about the latest data shared by peers\, and take advantage of the online networking and ‘Ask the Expert Speaker’ chatrooms. \nVisit the website to learn more and secure your place: https://ter.li/o6ghqw
URL:https://www.pharmajournalist.com/event/jak-inhibitors-drug-development-summit-running-digitally-for-2020/
LOCATION:Online
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200707
DTEND;VALUE=DATE:20200710
DTSTAMP:20260515T052528
CREATED:20200520T091348Z
LAST-MODIFIED:20200520T091348Z
UID:25596-1594080000-1594339199@www.pharmajournalist.com
SUMMARY:Onco Cell Therapy Summit
DESCRIPTION:Onco Cell Therapy Summit (OCTS)\, formerly the CAR-T Congress\, is the leading digital event revolutionizing patient outcomes in cancer therapies. \nThis virtual summit\, taking place June 7 – 9\, spans across 3 half days\, bringing you opportunities to share novel research\, manufacturing techniques and regulatory best practice through virtual panel discussion\, traditional presentations\, polls and round tables\, all from the comfort of your own home. Each session at OCTS 2020 is dedicated to encouraging knowledge sharing and translating novel data assets and IP into commercially viable oncological therapies. \n \nOCTS is a 4-track event and whilst bringing together the key decision makers for CAR-T therapies\, it also focuses on ground breaking science that is driving the surge of interest in harnessing alternative cell therapies in cancer treatments. \nWith 2 of our tracks comprised of research on CAR-T and alternative cell therapies\, the other pillar in rolling out these therapies is increasing the affordability of the treatments. The other two tracks will delve into best practice in commercialization and manufacturing of immuno-oncological cell therapies. \nEach day includes plenty of opportunities to network and there’s multiple panel discussions to also take a deep dive into the key challenges in major topics to R&D\, manufacturing and commercialization. \nThis is one must attend virtual event in the cell therapy field.
URL:https://www.pharmajournalist.com/event/onco-cell-therapy-summit/
LOCATION:Virtual\, EDT Timezone
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200709
DTEND;VALUE=DATE:20200710
DTSTAMP:20260515T052528
CREATED:20200619T121040Z
LAST-MODIFIED:20200619T121040Z
UID:25993-1594252800-1594339199@www.pharmajournalist.com
SUMMARY:Direct to Patient and Virtual Clinical Trials – Digital Experience
DESCRIPTION:With COVID-19 creating worldwide disruption in clinical trials and companies looking for innovative approaches to keep trials going\, we at Arena International are delighted to announce the launch of our Direct to Patient and Virtual Clinical Trials Digital Experience. \n \nThis one-day online event will bring together top-class speakers from around the world to discuss themes including remote monitoring\, temperature control in direct-to-patient shipments\, regulations and compliance\, and how to engage patients throughout a virtual trial. \nAlongside listening to presenters in our auditorium\, attendees will have the opportunity to visit our virtual exhibition hall\, chat in our networking lounge\, and set up 1:1 business meetings. \nThis event will be a crucial platform for clinical trials professionals to learn about how to adapt to direct-to-patient and virtual trials in a COVID and post-COVID world\, making it an unmissable event in your calendar.
URL:https://www.pharmajournalist.com/event/direct-to-patient-and-virtual-clinical-trials-digital-experience/
LOCATION:Virtual Event
ORGANIZER;CN="Arena International":MAILTO:Kadin.luong@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200715
DTEND;VALUE=DATE:20200716
DTSTAMP:20260515T052528
CREATED:20200624T102414Z
LAST-MODIFIED:20200624T102414Z
UID:26017-1594771200-1594857599@www.pharmajournalist.com
SUMMARY:Clinical Operations In Oncology Trials
DESCRIPTION:To keep pace with the health needs of the growing number of young and old afflicted with cancer globally\, clinical development in oncology is one of the fastest growing areas within the Pharma industry. At this unique virtual event\, attendees will get to learn strategies to better manage communication and relationships between trial sponsors and CROs\, learn ways to create patient-centric trials for higher enrolment rates including addressing the need for more diverse recruitment and much more. Key presenters on the line-up consist of C-level and director-level executives from the likes of Tufts Medical School\, Beat AML\, Pfizer and Agios Pharmaceutical.\nURL: https://arena-international.com/oncologyvirtual/
URL:https://www.pharmajournalist.com/event/clinical-operations-in-oncology-trials/
LOCATION:Vitual Event
ORGANIZER;CN="Arena International":MAILTO:alex.fearn@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20200715T090000
DTEND;TZID=Europe/Paris:20200715T181500
DTSTAMP:20260515T052528
CREATED:20200313T110619Z
LAST-MODIFIED:20200529T113416Z
UID:24619-1594803600-1594836900@www.pharmajournalist.com
SUMMARY:Gene Therapy for Neurological Disorders Europe
DESCRIPTION:Gene Therapy for Neurological Disorders Europe is dedicated to solving the translational drug development challenges encountered in the development of gene therapies for neurological disorders. \n \nIndustry pioneers from the leading pharma and biotech companies including Avexis\, uniQure\, and Biogen will share how to improve the translatability of small and large animal models\, develop innovative delivery approaches to guarantee delivery of vector and understand the realities of immunogenicity challenges in the CNS. \nJoin this definitive\, niche digital conference to accelerate the development of your gene therapy pipeline and address the significant unmet need in neurological indications.
URL:https://www.pharmajournalist.com/event/gene-therapy-for-neurological-disorders-europe/
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200716
DTEND;VALUE=DATE:20200717
DTSTAMP:20260515T052528
CREATED:20200611T142323Z
LAST-MODIFIED:20200611T142735Z
UID:25854-1594857600-1594943999@www.pharmajournalist.com
SUMMARY:Prefilled Syringe Elastomer Components - High-quality Solutions for Sensitive Molecules
DESCRIPTION:Join the experts on this free exclusive webinar on the 16th July 2020 at 2pm BST\, hosted by West Pharmaceutical Services\, Inc. \nAs the industry continues to see significant growth for drug products developed in prefilled syringe systems (PFS)\, there is a trend for pharmaceutical companies to evaluate more complex drug molecules\, such as biologics. \nThis webinar discusses current trends in the market for injectable drug delivery and outlines current challenges for companies developing drug products in a prefillable syringe system. \n \nWebinar Overview \nIncreasing demands on quality\, stringent regulations\, trends towards home care treatments by using innovative device technology\, and the development of specialized\, high-value treatments present challenges to companies looking for unique solutions. \nIn this webinar we will cover new elastomer component leading with innovation excellence developed to address the ever-increasing demands. Discussing the challenges of the pharmaceutical industry driven towards components being essentially free of particulate and meeting customer demand for consistency by assuring dimensional stability. \nFor more information on the webinar and to register your free place\, please visit: www.pfs-elastomer-components-webinar.com/mp
URL:https://www.pharmajournalist.com/event/prefilled-syringe-elastomer-components-high-quality-solutions-for-sensitive-molecules/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200716
DTEND;VALUE=DATE:20200717
DTSTAMP:20260515T052528
CREATED:20200624T102919Z
LAST-MODIFIED:20200624T102919Z
UID:26023-1594857600-1594943999@www.pharmajournalist.com
SUMMARY:Medical Device Trials
DESCRIPTION:At our first Medical Device Trials virtual event our aim is to support trial sponsors and solution providers internationally to ensure trials are delivered on time\, partnerships are improved and innovations are showcased\, discussing\, deliberating and debating the latest operational and technological challenges with regards to clinical trial in medical devices. Hear talks from Bassil Akra\, Faouzi Kallel from Edwards Lifesciences and many other industry leaders and disrupters!\nURL: https://arena-international.com/ctmd/
URL:https://www.pharmajournalist.com/event/medical-device-trials/
LOCATION:Virtual Event
ORGANIZER;CN="Arena International":MAILTO:alex.fearn@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200716
DTEND;VALUE=DATE:20200717
DTSTAMP:20260515T052528
CREATED:20200707T121728Z
LAST-MODIFIED:20200707T122000Z
UID:26229-1594857600-1594943999@www.pharmajournalist.com
SUMMARY:EXCLUSIVE FREE WEBINAR ON Prefilled Syringe Elastomer Components High-quality Solutions for Sensitive Molecules
DESCRIPTION:Join the experts at this free exclusive webinar on the 16th July 2020 at 2pm BST\, hosted by West Pharmaceutical Services\, Inc.We have had over 90 registrations so far\, joining us from:Abbvie\, Aptar\, Aptar Pharma\, BI Pharma GmbH & Co. KG\, BioQ Pharma Inc\, Datwyler\, DEKRA\, Hikma Pharmaceuticals\, j8 Process Consulting Taiwan\, Janssen\, Kansai Plascon\, Lazard\, Lilly\, Nemera\, Novartis\, Ohio State University\, Pfizer Inc\, Regeneron\, Roche\, Sanofi\, Sanofi Pasteur\, Schott\, SCHOTT France\, Sio2 Materials Science\, Softeq\, Sumitomo Rubber North America\, Sun pharma research center\, TUV Italia srl\, TUV Italy\, Vetter Pharma-Fertigung GmbH & Co. KG\, Weiss-Aug Co\, Inc.\, WL Gore\, Zacros (Fujimori Kogyo co. ltd.) and many more!\nWith only less than 2 weeks to go\, if you haven’t already registered your FREE place book your virtual seat here today!Can’t make the date/time? Register your place at the above link and we will send you the webinar\, post event.  \nWebinar OverviewIncreasing demands on quality\, stringent regulations\, trends towards home care treatments by using innovative device technology\, and the development of specialized\, high-value treatments present challenges to companies looking for unique solutions.In this webinar we will cover new elastomer component leading with innovation excellence developed to address the ever-increasing demands. Additionally\, we discuss the challenges of the pharmaceutical industry driven towards components being essentially free of particulate and meeting customer demand for consistency by assuring dimensional stability.Expert Webinar Hosts from West Pharmaceutical Services\, Inc.Christa Jansen-Otten\,Product Management\, Prefilled Systems & DeliveryWhitney Winters\,Senior Director\, Strategic Marketing and container SystemsFind out more information on the webinar hosts here. \nFor more information on the webinar and to register your free place\,\nplease visit: www.pfs-elastomer-components-webinar.com
URL:https://www.pharmajournalist.com/event/exclusive-free-webinar-on-prefilled-syringe-elastomer-components-high-quality-solutions-for-sensitive-molecules/
LOCATION:Webinar
ORGANIZER;CN="SMi Group":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200722
DTEND;VALUE=DATE:20200723
DTSTAMP:20260515T052528
CREATED:20200302T091243Z
LAST-MODIFIED:20200514T082403Z
UID:24438-1595376000-1595462399@www.pharmajournalist.com
SUMMARY:Innate Immune Stimulating Therapies Summit – Running Digitally for 2020
DESCRIPTION:Safely Harnessing Novel Targets of the Innate Immune System for Enhanced Anti-Tumor Effects \nThe inaugural Innate Immune Stimulating Therapies Summit is focused on achieving safe and effective clinical and commercial translation of STING and TLR therapies. \n \nJoin the leaders in the field\, from key biotech\, large pharma\, and academia\, to discuss how to optimize the administration of innate immune stimulating therapies from IT delivery through to antibody conjugated approaches. \nIf you are looking to make long lasting connections with industry leaders and take part in discussions about the lessons learned on the journey to translating safe and effective innate immune stimulating therapies for patients in need\, then this is the meeting for you. Join our online community of industry experts here: https://ter.li/52s56v. Earlybird and group discounts apply. Book early to secure the best possible rate on your ticket.
URL:https://www.pharmajournalist.com/event/innate-immune-stimulating-therapies-summit/
LOCATION:Online\, MA
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200722
DTEND;VALUE=DATE:20200723
DTSTAMP:20260515T052528
CREATED:20200612T152417Z
LAST-MODIFIED:20200612T155249Z
UID:25917-1595376000-1595462399@www.pharmajournalist.com
SUMMARY:RNAi-Based Therapeutics Summit – Running Digitally for 2020
DESCRIPTION:Digitally Join the RNAi-Based Therapeutics Community \nWe are excited to announce that the RNAi-Based Therapeutics Summit has gone virtual! \nAs the first multi-disciplinary discussion for large pharma\, biotech and academic leaders specifically dedicated to the RNAi therapeutics\, the industry will be coming together on Wednesday\, July 22 to successfully optimize cell-specific strategies\, overcome pharmacology and delivery challenges to accelerate translation and clinical development of RNAi therapeutics in the liver\, CNS and beyond. \nCheck out the official event guide for full speaker and session details. \nJoin this virtual summit to meet those pioneering the field and to hear from 19+ world-class experts that are sharing their latest perspectives: \n\nDong-ki Lee\, Founder & Chief Executive Officer\, OliX Pharmaceuticals\nElena Feinstein\, Chief Scientific Officer\, Quark Pharmaceuticals\nKaryn O’Neil\, Chief Scientific Officer\, Aro Biotherapeutics\nBrooke Rock\, Director\, Amgen\nSharmistha Ghosh\, Associate Director\, Arrowhead Pharmaceuticals\nBaisong Mei\, Senior Global Project Head\, Sanofi\nDavid Corey\, Professor\, UT Southwestern\n\nDownload the updated program to see the full list. \nWith several clinical candidates emerging and momentum building in the field\, join the RNAi-Based Therapeutics Summit – your comprehensive\, industry-focused virtual meeting dedicated to bringing together senior biopharmaceutical leaders from discovery\, translation\, and clinical development functions to advance pioneering RNAi platforms that improve patient outcomes. Secure your ticket now. \nLooking forward to seeing you at our virtual meeting!
URL:https://www.pharmajournalist.com/event/rnai-based-therapeutics-summit-running-digitally-for-2020/
LOCATION:Virtual Event
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200804
DTEND;VALUE=DATE:20200807
DTSTAMP:20260515T052528
CREATED:20200228T095936Z
LAST-MODIFIED:20200608T092435Z
UID:24358-1596499200-1596758399@www.pharmajournalist.com
SUMMARY:Gene Therapy Immunogenicity
DESCRIPTION:Gene therapies are revolutionizing the therapeutic landscape for rare and inherited diseases. For the field to progress\, however\, there are several unique and complex challenges. Perhaps the most prominent of these challenges is the immune response to gene therapy delivery. \n \nThe inaugural Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better measure\, modulate and predict immune response to your gene therapy candidate. \nUniting industry leaders across the gene therapy space\, this multi-disciplinary forum will enable you to develop more effective and safe gene therapies by discussing how you can: \n\nIdentify and tailor novel capsid proteins for more specific targeting and immunologic evasion\nReduce AAV neutralizing antibodies\nConfidently assess immunosuppression strategies to dampen immune response\n\nAs the only conference dedicated to the immunogenicity of gene therapies\, this will be an unrivalled opportunity to join 80+ like-minded thought-leaders from cross-disciplines to foster new connections and partnerships. \nDownload the full event guide to learn more from companies including BioMarin\, Spark Therapeutics and Novartis.
URL:https://www.pharmajournalist.com/event/gene-therapy-immunogenicity/
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200812
DTEND;VALUE=DATE:20200813
DTSTAMP:20260515T052528
CREATED:20200624T103810Z
LAST-MODIFIED:20200624T103810Z
UID:26029-1597190400-1597276799@www.pharmajournalist.com
SUMMARY:Vaccines Virtual Conference
DESCRIPTION:Due to the current climate\, we have taken the initiative to launch our very first vaccines conference! Join industry experts from across the globe\, conversing in the latest innovations in COVID-19 and other leading vaccine studies. Brought directly to your home –  listen to leading organisations such as GlaxoSmithKline\, Sanofi\, Pfizer along with leading biotech’s and is completely FREE! Featuring sessions COVID-19 Vaccine Updates\, overcoming manufacturing challenges within the industry \, managing clinical trials during a pandemic\, consideration needed in commercialising your vaccine and more\, this event is crucial to ensure you are up to date with the latest developments in the vaccine space. \n\nURL: https://arena-international.com/vaccine-virtual/
URL:https://www.pharmajournalist.com/event/vaccines-virtual-conference/
LOCATION:Virtual Event
ORGANIZER;CN="Arena International":MAILTO:alex.fearn@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200818
DTEND;VALUE=DATE:20200819
DTSTAMP:20260515T052528
CREATED:20200630T114013Z
LAST-MODIFIED:20200630T114013Z
UID:26126-1597708800-1597795199@www.pharmajournalist.com
SUMMARY:Hemophilia Drug Development Summit – Running Digitally for 2020
DESCRIPTION:With the recent Hemlibra approval and the gene therapy revolution\, we are seeing a much-needed race to innovate more effective\, long-lasting and curative therapies for hemophilia and acquired bleeding disorders. \nAs such\, the 3rd Hemophilia Drug Development Summit is going digital and remains dedicated to bringing to patients more effective commercially and clinically translated therapies from small molecules to gene therapies to improve patients’ quality of life. \n \nBringing together over 100 of the world’s leading experts and drug developers\, we discuss how to develop new therapies for a responsive subset of hemophiliac patients\, optimize clinical trial development (setup and management) and discuss the patient/payer paradigm to ensure these novel therapies are affordable and accessible. \nBrought direct to your home office with a jam packed agenda and online virtual networking opportunities\, this exclusive virtual summit will delve into the challenges of treating each patient subset\, as well as hearing the latest advancements in gene therapy and discussing the critical hurdles that need to be overcome to meet the unmet clinical need of all patients. \nJoin us as we unite drug developers and researchers on a dedicated online platform and look to the innovation driving the field towards more long-acting and curative therapies to improve patient quality of life. \nTo know more about Hemophilia Drug Development Summit please click here.
URL:https://www.pharmajournalist.com/event/hemophilia-drug-development-summit-running-digitally-for-2020/
LOCATION:Virtual Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR